EUVIMEDEUVIMED entdecken
Klinische Studie

Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions

K Liang Zeng, Ahmed Abugarib, Hany Soliman, Sten Myrehaug, Zain A Husain, Jay Detsky, Mark Ruschin, Aliaksandr Karotki, Eshetu G Atenafu, Jeremie Larouche, Mikki Campbell, Pejman Maralani und 2 weitere

International Journal of Radiation Oncology*Biology*Physics · 2023-03 · 115 (3) · 686-695

DOI: 10.1016/j.ijrobp.2022.09.076 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2023-03. Verfasst von K Liang Zeng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Fractures, Compression, Radiosurgery, Spinal Fractures, Spinal Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Stereotactic body radiation therapy (SBRT) for spine metastases improves pain response rates compared with conventional external beam radiation therapy; however, the optimal fractionation schedule is unclear. We report local control and toxicity outcomes after dose-escalated 2-fraction spine SBRT. METHODS AND MATERIALS: A prospectively maintained institutional database of over 600 patients and 1400 vertebral segments treated with spine SBRT was reviewed to identify those prescribed 28 or 24 Gy in 2 daily fractions. The primary endpoint was magnetic resonance imaging based local failure (LF), and secondary endpoints included overall survival and vertebral compression fracture (VCF). RESULTS: A total of 947 treated vertebral segments in 482 patients were identified, of which 301 segments in 159 patients received 28 Gy, and 646 segments in 323 patients received 24 Gy in 2 fractions. Median follow-up per patient was 23.5 months, and median overall survival was 49.1 months. In the 28 Gy cohort, the 6-, 12-, and 24-month cumulative incidences of LF were 3.5%, 5.4%, and 11.1%, respectively, versus 6.0%, 12.5%, and 17.6% in the 24 Gy cohort, respectively (P = .008). On multivariable analysis, 24 Gy (hazard ratio [HR], 1.525; 95% confidence interval, 1.039-2.238; P = .031), paraspinal disease extension (HR, 1.422; 95% confidence interval, 1.010-2.002; P = .044), and epidural extension in either radioresistant or radiosensitive histologies (HR, 2.117 and 1.227, respectively; P = .003) were prognostic for higher rates of LF. Risk of VCF was 5.5%, 7.6%, and 10.7% at 6, 12, and 24 months, respectively, and was similar between cohorts (P = .573). Spinal malalignment (P < .001), baseline VCF (P = .003), junctional spine location (P = .030), and greater minimum dose to 90% of planning target volume were prognostic for higher rates of VCF. CONCLUSIONS: Dose escalation to 28 Gy in 2 daily fractions was associated with improved local control without increasing the risk of VCF. The 2-year local control rates are consistent with those predicted by the Hypofractionated Treatment Effects in the Clinic spine tumor control probability model, and these data will inform a proposed dose escalation randomized trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fractures, CompressionRadiosurgerySpinal FracturesSpinal NeoplasmsHumansPrognosisSpine

Autor:innen und Institutionen

  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Clinical Oncology Department, Sohag University Hospital, Sohag, Egypt.
  • Department of Biostatistics, University Health Network, Toronto, Ontario, Canada.
  • Division of Orthopedic Surgery and Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: chia-lin.tseng@sunnybrook.ca.

Zitieren

APA

Zeng, K. L., Abugarib, A., Soliman, H., Myrehaug, S., Husain, Z. A., Detsky, J., Ruschin, M., Karotki, A., Atenafu, E. G., Larouche, J., Campbell, M., Maralani, P., Sahgal, A., & Tseng, C. L. (2023). Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions. International Journal of Radiation Oncology*Biology*Physics, 115(3), 686-695. https://doi.org/10.1016/j.ijrobp.2022.09.076

Vancouver

Zeng KL, Abugarib A, Soliman H, Myrehaug S, Husain ZA, Detsky J, et al. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions. International Journal of Radiation Oncology*Biology*Physics. 2023;115(3):686-695. doi:10.1016/j.ijrobp.2022.09.076

BibTeX
@article{Zeng2023,
  author = {Zeng, K Liang and Abugarib, Ahmed and Soliman, Hany and Myrehaug, Sten and Husain, Zain A and Detsky, Jay and Ruschin, Mark and Karotki, Aliaksandr and Atenafu, Eshetu G and Larouche, Jeremie and Campbell, Mikki and Maralani, Pejman and Sahgal, Arjun and Tseng, Chia-Lin},
  title = {Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2023},
  volume = {115},
  number = {3},
  pages = {686--695},
  doi = {10.1016/j.ijrobp.2022.09.076}
}
Kostenlos starten →